Placental-specific sFLT-1: role in pre-eclamptic pathophysiology and its translational possibilities for clinical prediction and diagnosis.
about
Recent Advances in Hypertension and Cardiovascular Toxicities With Vascular Endothelial Growth Factor Inhibition.Maternal serum autotaxin levels in early- and late-onset preeclampsia.Combining metformin and esomeprazole is additive in reducing sFlt-1 secretion and decreasing endothelial dysfunction - implications for treating preeclampsia.Positive and Negative Regulation of Angiogenesis by Soluble Vascular Endothelial Growth Factor Receptor-1.Causative Effects of Genetically Determined High Maternal/Fetal Endothelin-1 on Preeclampsia-Like Conditions in Mice.
P2860
Placental-specific sFLT-1: role in pre-eclamptic pathophysiology and its translational possibilities for clinical prediction and diagnosis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Placental-specific sFLT-1: rol ...... ical prediction and diagnosis.
@en
Placental-specific sFLT-1: rol ...... ical prediction and diagnosis.
@nl
type
label
Placental-specific sFLT-1: rol ...... ical prediction and diagnosis.
@en
Placental-specific sFLT-1: rol ...... ical prediction and diagnosis.
@nl
prefLabel
Placental-specific sFLT-1: rol ...... ical prediction and diagnosis.
@en
Placental-specific sFLT-1: rol ...... ical prediction and diagnosis.
@nl
P2093
P2860
P50
P356
P1476
Placental-specific sFLT-1: rol ...... ical prediction and diagnosis.
@en
P2093
K R Palmer
T J Kaitu'u-Lino
P2860
P356
10.1093/MOLEHR/GAW077
P577
2016-12-16T00:00:00Z